Quest Diagnostics

DGX · Health Care · Market cap $25.9B

Q4 FY25 Oct 1 – Dec 31, 2025 reported Feb 26, 2026

Revenue$2.8B +7% year over year

Gross profit$0.9B

Operating profit$0.4B

Net profit$0.2B 9% margin

Numbers and detail

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Dec 31, 2025).
Item	Value	Share of revenue	Year over year
Revenue	2.8	100%	+7%
Diagnostic Information	2.7	96%	+7%
All Other Segments	0.1	4%	−2%
Cost of revenue	−1.9	68%
Gross profit	0.9	32% margin	+0pp
SG&A	−0.5	18%	+0pp
Other	−0	1%	+0pp
Operating profit	0.4	14% margin	+0pp
Tax	−0.1
Interest & other costs	−0.1
Net profit	0.2	9%	+0pp

All figures in billions of U.S. dollars, for Q3 FY24 (period ends Sep 30, 2024).
Item	Value	Share of revenue	Year over year
Revenue	2.5	100%	+8%
Diagnostic Information	2.4	96%	+9%
All Other Segments	0.1	4%	−9%
Cost of revenue	−1.7	68%
Gross profit	0.8	33% margin	+0pp
SG&A	−0.4	18%	+1pp
Other	−0	1%	+0pp
Operating profit	0.3	13% margin	−2pp
Tax	−0.1
Net profit	0.2	9%	−1pp

Quarter by quarter

Pick a quarter and the diagram above changes. Bars compare revenue across the quarters we hold.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q4 FY25	Oct 1 – Dec 31, 2025	Feb 26, 2026	$2.8B	+7%	14%	$0.2B	9%
Q3 FY24	Jul 1 – Sep 30, 2024	Oct 23, 2024	$2.5B	+8%	12%	$0.2B	9%